​
​

Pliant Therapeutics Ownership | Who Owns Pliant Therapeutics?

OverviewForecastRevenueFinancialsChart

Pliant Therapeutics Ownership Summary

Pliant Therapeutics is owned by 106.18% institutional investors, 2.86% insiders. Deep track capital, lp is the largest institutional shareholder, holding 9.92% of PLRX shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 3.97% of its assets in Pliant Therapeutics shares.

PLRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPliant Therapeutics106.18%2.86%-9.04%
SectorHealthcare Stocks 46.62%8.13%45.25%
IndustryBiotech Stocks 44.91%7.98%47.11%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Deep track capital, lp5.97M9.92%$64.20M
Blackrock4.97M8.26%$53.45M
Price t rowe associates inc /md/4.60M7.65%$49.48M
Fmr3.91M6.50%$42.05M
Vanguard group3.44M5.71%$36.95M
First light asset management3.40M5.65%$36.56M
Redmile group3.21M5.33%$34.50M
Blue owl capital lp3.00M4.99%$32.30M
Great point partners2.64M4.38%$28.35M
Trv gp iv2.13M3.54%$22.93M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mass general brigham288.69K15.11%$3.10M
Trv gp iv2.13M11.34%$22.93M
Blue owl capital lp3.00M8.98%$32.30M
Great point partners2.64M5.43%$28.35M
First light asset management3.40M3.21%$36.56M
Redmile group3.21M2.09%$34.50M
Deep track capital, lp5.97M1.92%$64.20M
Fernwood investment management496.29K1.65%$5.34M
Checkpoint capital232.20K1.50%$2.50M
Exome asset management124.00K1.19%$1.33M

Top Buyers

HolderShares% AssetsChange
Great point partners2.64M5.43%785.00K
Price t rowe associates inc /md/4.60M0.01%643.24K
Blackrock4.97M0.00%316.25K
Morgan stanley673.85K0.00%289.75K
Candriam s.c.a.833.22K0.05%285.22K

Top Sellers

HolderShares% AssetsChange
Laurion capital management lp---2.50M
Capital investors225.00K0.00%-1.15M
Casdin capital---1.00M
Franklin resources1.02M0.00%-511.86K
Ameriprise financial---371.13K

New Positions

HolderShares% AssetsChangeValue
Checkpoint capital232.20K1.50%232.20K$2.50M
Trexquant investment lp158.70K0.03%158.70K$1.71M
Rice hall james & associates127.63K0.08%127.63K$1.37M
Squarepoint ops80.47K0.00%80.47K$865.11K
Ubs oconnor77.00K0.05%77.00K$827.75K

Sold Out

HolderChange
Mine & arao wealth creation & management, llc.-2.00
Nelson, van denburg & campbell wealth management group-11.00
Financial gravity asset management-19.00
Eversource wealth advisors-59.00
Quarry lp-104.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241484.96%63,899,831-1.97%1060.91%7821.88%33-10.81%
Mar 31, 2024141-65,187,2223.95%1080.95%64-9.86%3715.63%
Dec 31, 2023141-1.40%62,712,6683.67%1061.04%71-4.05%32-
Sep 30, 2023143-6.54%60,491,6723.91%1011.05%74-18.68%32-20.00%
Jun 30, 2023153-58,215,8463.52%980.98%91-8.08%4033.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
US Small-Cap Growth II Equity Comp2.41M3.97%-96.40K
T. Rowe Price New Horizons2.41M3.97%-95.38K
Vanguard Total Stock Mkt Idx Inv2.03M3.34%2.72K
Polar Capital Biotech S Inc1.85M3.04%-
Fidelity Growth Compy Commingled Pl S1.78M2.93%11.12K
Fidelity Growth Compy Commingled Pl O1.77M2.91%-
iShares Russell 2000 ETF1.46M2.40%-3.29K
Fidelity Growth Company Fund1.32M2.18%-2.81K
DWS ESG Akkumula LC1.30M2.14%5.00
Vanguard Institutional Extnd Mkt Idx Tr873.40K1.44%14.52K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 10, 2024Lefebvre Eric Chief Medical OfficerSell$142.41K
Jul 10, 2024Hull Hans Chief Business OfficerSell$114.44K
Jul 10, 2024Cummings Keith Lamont Chief Financial OfficerSell$126.13K
Jul 10, 2024Coulie Bernard President and CEOSell$447.49K
Jul 10, 2024Ouimette Mike General Counsel & Corp. Sec'ySell$88.50K

Insider Transactions Trends

DateBuySell
2024 Q3-5
2024 Q2--
2024 Q1-5
2023 Q3-9
2023 Q2-2

PLRX Ownership FAQ

Who Owns Pliant Therapeutics?

Pliant Therapeutics shareholders are primarily institutional investors at 106.18%, followed by 2.86% insiders and -9.04% retail investors. The average institutional ownership in Pliant Therapeutics's industry, Biotech Stocks , is 44.91%, which Pliant Therapeutics exceeds.

Who owns the most shares of Pliant Therapeutics?

Pliant Therapeutics’s largest shareholders are Deep track capital, lp (5.97M shares, 9.92%), Blackrock (4.97M shares, 8.26%), and Price t rowe associates inc /md/ (4.6M shares, 7.65%). Together, they hold 25.83% of Pliant Therapeutics’s total shares outstanding.

Does Blackrock own Pliant Therapeutics?

Yes, BlackRock owns 8.26% of Pliant Therapeutics, totaling 4.97M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 53.45M$. In the last quarter, BlackRock increased its holdings by 316.25K shares, a 6.79% change.

Who is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested?

Mass general brigham is Pliant Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.11% of its assets in 288.69K Pliant Therapeutics shares, valued at 3.1M$.

Who is the top mutual fund holder of Pliant Therapeutics shares?

US Small-Cap Growth II Equity Comp is the top mutual fund holder of Pliant Therapeutics shares, with 3.97% of its total shares outstanding invested in 2.41M Pliant Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools